Hypertrophic cardiomyopathy anatomic abnormalities: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:
Individuals with HCM have some degree of [[left ventricular hypertrophy]]. In approximately 2/3rds of cases this is an asymmetric hypertrophy, involving the inter-ventricular septum, and is known as [[asymmetric septal hypertrophy]] ([http://www.cardiomyopathy.org/html/which_card_hcm.htm ASH]). This is in contrast to the symmetric and concentric hypertrophy seen in [[aortic stenosis]] or [[hypertension]].
Individuals with HCM have some degree of [[left ventricular hypertrophy]]. In approximately 2/3rds of cases this is an asymmetric hypertrophy, involving the inter-ventricular septum, and is known as [[asymmetric septal hypertrophy]] ([http://www.cardiomyopathy.org/html/which_card_hcm.htm ASH]). This is in contrast to the symmetric and concentric hypertrophy seen in [[aortic stenosis]] or [[hypertension]].


==Hypertrophy==
==Left Ventricular Hypertrophy==
The degree of ventricular hypertrophy is variable ranging from diffuse involvement of both ventricles to isolated involvement of a portion of one segment of the [[LV]].   
The degree of ventricular hypertrophy is variable ranging from diffuse involvement of both ventricles to isolated involvement of a portion of one segment of the [[LV]].   



Revision as of 19:47, 14 August 2011

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertrophic cardiomyopathy anatomic abnormalities On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy anatomic abnormalities

CDC on Hypertrophic cardiomyopathy anatomic abnormalities

Hypertrophic cardiomyopathy anatomic abnormalities in the news

Blogs on Hypertrophic cardiomyopathy anatomic abnormalities

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy anatomic abnormalities

Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Individuals with HCM have some degree of left ventricular hypertrophy. In approximately 2/3rds of cases this is an asymmetric hypertrophy, involving the inter-ventricular septum, and is known as asymmetric septal hypertrophy (ASH). This is in contrast to the symmetric and concentric hypertrophy seen in aortic stenosis or hypertension.

Left Ventricular Hypertrophy

The degree of ventricular hypertrophy is variable ranging from diffuse involvement of both ventricles to isolated involvement of a portion of one segment of the LV.

Data from two large registries indicates that;

  • 55% of cases involve the septum and anterolateral free wall,
  • 20% involve the entire septum alone,
  • 10% are limited to the basal septum and 15% are limited to the apical or distal LV (Yamaguchi variant).

Some genetic variants may manifest very little overt LVH but are still associated with an increased risk of sudden cardiac death (SCD).

Outflow Tract

The left ventricular outflow tract is often small.

References